IL1B and lung carcinoma: Ridker Ridker PM PM MacFadyen MacFadyen JG JG Thuren Thuren T T Everett Everett BM BM Libby Libby P P Glynn Glynn RJ RJ Effect of interleukin-1beta inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial Effect of interleukin-1beta inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial Lancet Lancet 2017 2017 390 390 10105 10105 1833 1833 1842 1842 28855077 28855077